Loading…
Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review
In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current...
Saved in:
Published in: | Heart Asia 2019-06, Vol.11 (2), p.e011173-e011173 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373 |
---|---|
cites | cdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373 |
container_end_page | e011173 |
container_issue | 2 |
container_start_page | e011173 |
container_title | Heart Asia |
container_volume | 11 |
creator | Ni, Zhao Dardas, Latefa Wu, Bei Shaw, Ryan |
description | In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence. |
doi_str_mv | 10.1136/heartasia-2018-011173 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6590990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2246742184</sourcerecordid><originalsourceid>FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhSMEolXpTwBZ4sIl4HGcOOaAhFZAK1XiAmdrYk8arzb2Yme36r-vly2rwglfbI2_eXpPr6peA38P0HQfJsK0YPZYCw59zQFANc-qc1CtrgG4fP7kfVZd5rzm5TQgeyleVmcNCK2gE-dVWGFyPm5TXMgufk9sJuctLj4Ghm6iRMESwzmGW7YtYwpLZnd-mZiNKQZM9-y3G-Z8JszEfGCryQf8yJDl-7zQXLYsS7T3dPeqejHiJtPl431R_fz65cfqqr75_u169fmmHmTPlxpb3jvZqlFr23aKK0vaWacHxF4Oo9TQ617gaLkbCZwAqUaQIBGRbNeo5qL6dNTd7oYSyBbXCTdmm_xcHJuI3vz9E_xkbuPedK3mWvMi8O5RIMVfO8qLmX22tNlgoLjLRohWKd5ycUDf_oOu4y6FEq9QslNSQC8L1R4pm2LOicaTGeDmUKo5lWoOpZpjqWXvzdMkp60_FRaAH4FhXv-n5gPzOrI1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2246742184</pqid></control><display><type>article</type><title>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</title><source>PubMed</source><creator>Ni, Zhao ; Dardas, Latefa ; Wu, Bei ; Shaw, Ryan</creator><creatorcontrib>Ni, Zhao ; Dardas, Latefa ; Wu, Bei ; Shaw, Ryan</creatorcontrib><description>In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.</description><identifier>ISSN: 1759-1104</identifier><identifier>EISSN: 1759-1104</identifier><identifier>DOI: 10.1136/heartasia-2018-011173</identifier><identifier>PMID: 31297162</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Acute coronary syndromes ; Cardiology ; Cardiovascular disease ; Coronary vessels ; Global health ; Health care access ; Health risk assessment ; Heart ; Intervention ; Keywords ; Nursing ; Patient compliance ; Pharmaceuticals ; Public health ; Review ; Systematic review</subject><ispartof>Heart Asia, 2019-06, Vol.11 (2), p.e011173-e011173</ispartof><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</citedby><cites>FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</cites><orcidid>0000-0001-5437-4778 ; 0000-0002-9185-9894</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590990/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590990/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31297162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ni, Zhao</creatorcontrib><creatorcontrib>Dardas, Latefa</creatorcontrib><creatorcontrib>Wu, Bei</creatorcontrib><creatorcontrib>Shaw, Ryan</creatorcontrib><title>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</title><title>Heart Asia</title><addtitle>Heart Asia</addtitle><description>In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.</description><subject>Acute coronary syndromes</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><subject>Global health</subject><subject>Health care access</subject><subject>Health risk assessment</subject><subject>Heart</subject><subject>Intervention</subject><subject>Keywords</subject><subject>Nursing</subject><subject>Patient compliance</subject><subject>Pharmaceuticals</subject><subject>Public health</subject><subject>Review</subject><subject>Systematic review</subject><issn>1759-1104</issn><issn>1759-1104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqNkUFv1DAQhSMEolXpTwBZ4sIl4HGcOOaAhFZAK1XiAmdrYk8arzb2Yme36r-vly2rwglfbI2_eXpPr6peA38P0HQfJsK0YPZYCw59zQFANc-qc1CtrgG4fP7kfVZd5rzm5TQgeyleVmcNCK2gE-dVWGFyPm5TXMgufk9sJuctLj4Ghm6iRMESwzmGW7YtYwpLZnd-mZiNKQZM9-y3G-Z8JszEfGCryQf8yJDl-7zQXLYsS7T3dPeqejHiJtPl431R_fz65cfqqr75_u169fmmHmTPlxpb3jvZqlFr23aKK0vaWacHxF4Oo9TQ617gaLkbCZwAqUaQIBGRbNeo5qL6dNTd7oYSyBbXCTdmm_xcHJuI3vz9E_xkbuPedK3mWvMi8O5RIMVfO8qLmX22tNlgoLjLRohWKd5ycUDf_oOu4y6FEq9QslNSQC8L1R4pm2LOicaTGeDmUKo5lWoOpZpjqWXvzdMkp60_FRaAH4FhXv-n5gPzOrI1</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Ni, Zhao</creator><creator>Dardas, Latefa</creator><creator>Wu, Bei</creator><creator>Shaw, Ryan</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5437-4778</orcidid><orcidid>https://orcid.org/0000-0002-9185-9894</orcidid></search><sort><creationdate>20190601</creationdate><title>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</title><author>Ni, Zhao ; Dardas, Latefa ; Wu, Bei ; Shaw, Ryan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute coronary syndromes</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><topic>Global health</topic><topic>Health care access</topic><topic>Health risk assessment</topic><topic>Heart</topic><topic>Intervention</topic><topic>Keywords</topic><topic>Nursing</topic><topic>Patient compliance</topic><topic>Pharmaceuticals</topic><topic>Public health</topic><topic>Review</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ni, Zhao</creatorcontrib><creatorcontrib>Dardas, Latefa</creatorcontrib><creatorcontrib>Wu, Bei</creatorcontrib><creatorcontrib>Shaw, Ryan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (ProQuest Medical & Health Databases)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart Asia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ni, Zhao</au><au>Dardas, Latefa</au><au>Wu, Bei</au><au>Shaw, Ryan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review</atitle><jtitle>Heart Asia</jtitle><addtitle>Heart Asia</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>11</volume><issue>2</issue><spage>e011173</spage><epage>e011173</epage><pages>e011173-e011173</pages><issn>1759-1104</issn><eissn>1759-1104</eissn><abstract>In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>31297162</pmid><doi>10.1136/heartasia-2018-011173</doi><orcidid>https://orcid.org/0000-0001-5437-4778</orcidid><orcidid>https://orcid.org/0000-0002-9185-9894</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1759-1104 |
ispartof | Heart Asia, 2019-06, Vol.11 (2), p.e011173-e011173 |
issn | 1759-1104 1759-1104 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6590990 |
source | PubMed |
subjects | Acute coronary syndromes Cardiology Cardiovascular disease Coronary vessels Global health Health care access Health risk assessment Heart Intervention Keywords Nursing Patient compliance Pharmaceuticals Public health Review Systematic review |
title | Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardioprotective%20medication%20adherence%20among%20patients%20with%20coronary%20heart%20disease%20in%20China:%20a%20systematic%20review&rft.jtitle=Heart%20Asia&rft.au=Ni,%20Zhao&rft.date=2019-06-01&rft.volume=11&rft.issue=2&rft.spage=e011173&rft.epage=e011173&rft.pages=e011173-e011173&rft.issn=1759-1104&rft.eissn=1759-1104&rft_id=info:doi/10.1136/heartasia-2018-011173&rft_dat=%3Cproquest_pubme%3E2246742184%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b480t-a508d457f99c56707ce9dcd9baa84bf4918982afc0dfe1d2147f1414aaaec6373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2246742184&rft_id=info:pmid/31297162&rfr_iscdi=true |